An Open-label Study to Evaluate the Absorption, Metabolism, and Excretion of [14C]-Telotristat Etiprate in Males

Inclusion Criteria: * Healthy male subjects aged 30 to 65 years of age. * Male subjects and their partners must agree to use an adequate method of contraception * Historically able to produce a minimum of 1 bowel movement every day on most days Exclusion Criteria: * Female subjects * Use of any medication or supplement within 5 days prior to Dosing * Radiation exposure exceeding 5 millisieverts (mSv) in the last 12 months or 10 mSv in the last 5 years * Current smokers or the use of cigarettes within 90 days prior to Screening * History or renal disease or abnormal kidney function * History of hepatic disease * Acute diarrhea or constipation within 7 days of dosing * Positive urine glucose at Screening